John P. Feighner
Corporate Officer/Principal chez University of California San Diego
Profil
John P.
Feighner is the founder of the Institute for Creation Research, which was founded in 1984.
He held the title of Vice President & Medical Director in 1992.
Dr. Feighner is also the founder of Feighner Research Institute.
He is currently working at the University of California San Diego as a Clinical Professor-Psychiatry since 1970.
Dr. Feighner's former positions include being a Director at Tetragenex Pharmaceuticals, Inc. from 1999 to 2006, a Medical Director at San Luis Rey Equine Hospital in 1988, and a Director-Research & Education at Charter Hospital of Indianapolis in 1995.
Postes actifs de John P. Feighner
| Sociétés | Poste | Début |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 05/02/2010 |
Anciens postes connus de John P. Feighner
| Sociétés | Poste | Fin |
|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Directeur/Membre du Conseil | 02/01/2006 |
| Charter Hospital of Indianapolis | Directeur Technique/Scientifique/R&D | 02/01/1995 |
| Institute for Creation Research | Fondateur | 02/01/1992 |
| San Luis Rey Equine Hospital | Directeur Technique/Scientifique/R&D | 02/01/1988 |
| Feighner Research Institute | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| Feighner Research Institute | |
| San Luis Rey Equine Hospital | |
| Charter Hospital of Indianapolis | |
| Institute for Creation Research |
